Volitionrx (VNRX) Total Current Liabilities (2011 - 2025)

Volitionrx's Total Current Liabilities history runs 11 years deep, the most recent figure standing at $12.2 million for Q4 2025.

• Quarterly Total Current Liabilities rose 56.99% year-over-year to $12.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.2 million (up 56.99% YoY) and the FY2025 annual result came in at $12.2 million, up 56.99% from the prior year.
• Total Current Liabilities was $12.2 million for Q4 2025 at Volitionrx, up from $11.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $31.5 million in Q1 2024 and bottomed at $5.4 million in Q2 2021.
• A 5-year average of $15.3 million and a median of $17.0 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 221.42% — and 2025, when it plunged 73.73%.
• Volitionrx's Total Current Liabilities stood at $6.5 million in 2021, then jumped by 166.83% to $17.4 million in 2022, then plunged by 48.56% to $8.9 million in 2023, then retreated by 12.89% to $7.8 million in 2024, then jumped by 56.99% to $12.2 million in 2025.
• Business Quant data shows VNRX's Total Current Liabilities at $12.2 million in Q4 2025, $11.4 million in Q3 2025, and $9.2 million in Q2 2025.